Stock OVID OVID THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
3.05 USD +1.67% Intraday chart for Ovid Therapeutics Inc. -1.93% -5.28%
May. 14 Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 MT
May. 14 Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000
MT
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
GL
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
AQ
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GL
B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target
MT
HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target
MT
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
GL
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus Post Grant Review
AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ovid Therapeutics : Corporate Presentation
PU
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562
MT
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
GL
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
GL
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
AQ
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GL
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
BTIG Initiates Ovid Therapeutics With Buy Rating, Price Target is $11
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OVID Stock
  4. News Ovid Therapeutics Inc.